Forbius (also known as Formation Biologics) is a protein engineering company that develops biotherapeutics for the treatment of cancer and fibrotic diseases. It provides agents targeting the transforming growth factor-beta (TGF-beta) and epidermal growth factor receptor (EGFR) pathways.

TypeSubsidiary
Parent CompanyBristol-Myers Squibb
HQAustin, TX, US
Founded2011
Websiteforbius.com
Cybersecurity ratingAMore
Forbius was founded in 2011 and is headquartered in Austin, TX, US

Viewing summary data as a guest

Sign up for free to see all data
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Forbius

Ilia Tikhomirov

Ilia Tikhomirov

President and CEO, Director

Forbius Office Locations

Forbius has offices in Austin and Montréal
Austin, TX, US (HQ)
701 Brazos St #930
Montréal, CA
101-750 Boul St-Laurent
Show all (2)

Forbius Financials and Metrics

Summary Metrics

Founding Date

2011
Forbius is a subsidiary of Bristol-Myers Squibb

Forbius Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Forbius Online and Social Media Presence

Embed Graph

Forbius News and Updates

Bristol Myers Squibb Completes Acquisition of Forbius

Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its transaction to acquire Forbius for their TGF-beta program, including its lead investigational asset AVID200, currently in Phase 1 for oncology and fibrosis

Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding Lead TGF-beta Asset to Portfolio

Bristol Myers Squibb (NYSE: BMY) and Forbius, a privately held, clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases, today announced that they have entered into a definitive agreement under which Bristol Myers Squibb …

Forbius Completes Enrollment into Phase 1a Solid Tumor Trial of AVID200, First-in-Class TGF-beta 1 & 3 Inhibitor; Closes Series C Financing

Forbius, a clinical-stage protein engineering company that develops biotherapeutics to treat fibrosis and cancer, announced today that the Phase 1a solid tumor trial exploring the safety and tolerability of AVID200, a first-in-class TGF-beta 1 & 3 selective inhibitor, administered as a monothera…

Forbius Frequently Asked Questions

  • When was Forbius founded?

    Forbius was founded in 2011.

  • Who are Forbius key executives?

    Forbius's key executives are Ilia Tikhomirov.

  • How many employees does Forbius have?

    Forbius has 28 employees.

  • Who are Forbius competitors?

    Competitors of Forbius include Agios Pharmaceuticals, CytomX Therapeutics and Rakuten Medical.

  • Where is Forbius headquarters?

    Forbius headquarters is located at 701 Brazos St #930, Austin.

  • Where are Forbius offices?

    Forbius has offices in Austin and Montréal.

  • How many offices does Forbius have?

    Forbius has 2 offices.